Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.02)
# 1,463
Out of 5,030 analysts
334
Total ratings
42.07%
Success rate
0.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $69.15 | +15.69% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $67.03 | +11.89% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $73.09 | -11.07% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $4.49 | +211.80% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $42.15 | +137.25% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $27.48 | +63.76% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $31.96 | +134.67% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $14.50 | +106.90% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $20.99 | +109.62% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $22.51 | -55.58% | 14 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $16.50 | -39.39% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $24.75 | +21.21% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $19.09 | +554.96% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $15.35 | -2.28% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.37 | +264.96% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $6.63 | -24.59% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.20 | +56.25% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $9.58 | +56.58% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $29.03 | +55.01% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $3.77 | -20.42% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $8.99 | +344.89% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.54 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $3.05 | +129.51% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $3.21 | -6.54% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $0.54 | +268.80% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.64 | +448.78% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $5.38 | +178.81% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40,000 → $610,000 | $0.33 | +187,059,084.30% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $4.97 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $69.15
Upside: +15.69%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $67.03
Upside: +11.89%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $73.09
Upside: -11.07%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $4.49
Upside: +211.80%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $42.15
Upside: +137.25%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $27.48
Upside: +63.76%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $31.96
Upside: +134.67%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $14.50
Upside: +106.90%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $20.99
Upside: +109.62%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $22.51
Upside: -55.58%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $16.50
Upside: -39.39%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $24.75
Upside: +21.21%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $19.09
Upside: +554.96%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $15.35
Upside: -2.28%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.37
Upside: +264.96%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $6.63
Upside: -24.59%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $3.20
Upside: +56.25%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $9.58
Upside: +56.58%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $29.03
Upside: +55.01%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $3.77
Upside: -20.42%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $8.99
Upside: +344.89%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.54
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $3.05
Upside: +129.51%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $3.21
Upside: -6.54%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $0.54
Upside: +268.80%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.64
Upside: +448.78%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $5.38
Upside: +178.81%
Sep 6, 2023
Maintains: Buy
Price Target: $40,000 → $610,000
Current: $0.33
Upside: +187,059,084.30%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $4.97
Upside: -